Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5 by Zhu, Guangyu et al.
EMBO
open
Structure of the APPL1 BAR-PH domain and
characterization of its interaction with Rab5
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
distribution,andreproductioninanymedium,providedtheoriginalauthorandsourcearecredited.Thislicensedoesnot
permit commercialexploitation or the creationof derivative works without speciﬁc permission.
Guangyu Zhu
1, Jia Chen
2, Jay Liu
3,
Joseph S Brunzelle
4, Bo Huang
2,
Nancy Wakeham
1, Simon Terzyan
1,
Xuemei Li
2, Zihe Rao
2, Guangpu Li
3
and Xuejun C Zhang
1,2,*
1Crystallography Research Program, Oklahoma Medical Research
Foundation, Oklahoma City, OK, USA,
2National Laboratory of
Biomacromolecules, Institute of Biophysics, Chinese Academy of
Sciences, Beijing, China,
3Department of Biochemistry and Molecular
Biology, University of Oklahoma Health Sciences Center, Oklahoma
City, OK, USA and
4Department of Molecular Pharmacology and
Biological Chemistry, Feinberg Medical School, Northwestern
University, Chicago, IL, USA
APPL1 is an effector of the small GTPase Rab5. Together,
they mediate a signal transduction pathway initiated by
ligand binding to cell surface receptors. Interaction with
Rab5 is conﬁned to the amino (N)-terminal region of
APPL1. We report the crystal structures of human APPL1
N-terminal BAR-PH domain motif. The BAR and PH do-
mains, together with a novel linker helix, form an inte-
grated, crescent-shaped, symmetrical dimer. This BAR–PH
interaction is likely conserved in the class of BAR-PH
containing proteins. Biochemical analyses indicate two
independent Rab-binding sites located at the opposite
ends of the dimer, where the PH domain directly interacts
with Rab5 and Rab21. Besides structurally supporting the
PH domain, the BAR domain also contributes to Rab
binding through a small surface region in the vicinity of
the PH domain. In stark contrast to the helix-dominated,
Rab-binding domains previously reported, APPL1 PH do-
main employs b-strands to interact with Rab5. On the Rab5
side, both switch regions are involved in the interaction.
Thus we identiﬁed a new binding mode between PH
domains and small GTPases.
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Introduction
Endocytosis induced by ligand receptor interaction has been
directly linked to signal transduction mediated by Rab5 and
its effector APPL1 (Adaptor protein containing PH domain
PTB domain and Leucine zipper motif; Miaczynska et al,
2004; Mao et al, 2006). The small GTPase Rab5 is a generally
acknowledged prominent regulator of vesicle trafﬁcking en-
route from the plasma membrane to early endosomes (Li,
1996), whereas APPL1 (also called DIP13a) is identiﬁed with
signaling pathways of adiponectin, insulin, EGF, follicle
stimulating hormone receptor, neurotrophin receptor
(TrkA), oxidative stress, and DCC-mediated apoptosis (Liu
et al, 2002; Miaczynska et al, 2004; Lin et al, 2006; Mao et al,
2006; Varsano et al, 2006; Nechamen et al, 2007). Within this
milieu, APPL1 speciﬁcally binds to the GTP-bound, active
form of Rab5. In response to extracellular stimuli, Rab5
hydrolyzes its bound GTP, releasing APPL1 from an endocytic
structure, and allowing APPL1 to further interact with com-
ponents of nucleosome remodeling and histone deacetylase
complexes. The interaction with Rab5 is essential for APPL1
localization to the endosomes and is indispensable for the
functional cycle of APPL1 (Miaczynska et al, 2004).
Human APPL1, a multidomain protein 709 amino-acid (aa)
residues in length contains an amino (N)-terminal BAR
(Bin1/Amphiphysin/RVS167) domain and a PH (pleckstrin
homology) domain followed by a carboxy (C)-terminal PTB
(phosphotyrosine binding) domain (Sakamuro et al, 1996;
Liu et al, 2002; Miaczynska et al, 2004). The Rab5-binding
site is located in the N-terminal BAR-PH region (Miaczynska
et al, 2004), while the C-terminal region is found to interact
with a host of other proteins, including the adiponectin
receptor (Mao et al, 2006), Akt2/PKBb kinase (Mitsuuchi
et al, 1999), tumor suppressor DCC (Liu et al, 2002), TrkA,
and TrkA interacting protein GIPC1 (Lin et al, 2006).
Based on aa sequence analysis, BAR domains have been
identiﬁed in many proteins involved in intracellular trafﬁck-
ing, but sequence homology is low in general among known
BAR domains (Farsad et al, 2001; Habermann, 2004). The
BAR domain typically contains three long kinked a-helices
(a1, a2, and a3) that form a well-packed, crescent-shaped,
symmetrical, six-helix bundle, side-by-side antiparallel
homodimer; a structure proposed to exert its function as a
convex membrane-curvature sensor or stabilizer. The con-
cave surface of the BAR dimer is proposed to bind preferen-
tially to a negatively charged, curved membrane largely
through electrostatic interactions. Furthermore, some BAR
domains have been found to bind to small GTPases, a class of
intracellular molecular switches (Tarricone et al,2 0 0 1 ;
Habermann, 2004); thus, their membrane association is
directly linked to regulation of signal transduction and traf-
ﬁcking. However, currently available structural information
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3484suggests that bindings of the BAR domain to GTPases and to
membrane lipids are incompatible, because both interactions
appear to compete for the same concave surface region of the
BAR dimer (Tarricone et al, 2001). The BAR domain of APPL1
is required for Rab5 binding and membrane recruitment
(Miaczynska et al, 2004), although the mechanisms remain
to be elucidated.
The PH domain is approximately 100-residue long, and has
been identiﬁed in over 100 different eukaryotic proteins such
as kinases, isoforms of phospholipase C (PLC), GTPases, and
their regulators; most of which participate in cell signaling
and cytoskeletal regulation (Rebecchi and Scarlata, 1998).
Despite their minimal sequence homology, the three-dimen-
sional (3D) structures of PH domains are remarkably con-
served. They possess a common core consisting of seven
b-strands and a C-terminal a-helix (Rebecchi and Scarlata,
1998). Some PH domains speciﬁcally bind to phosphatidyl-
inositol phosphates, suggesting that one possible function of
this family is to anchor the host proteins to membranes. PH
domains are also suggested to bind to the Gbg complex of the
heterotrimeric G protein, protein kinase C, and small
GTPases. Nevertheless, none of these functions is absolutely
conserved. For instance, the PH domain of APPL1 alone is
insufﬁcient for binding to the membrane (Miaczynska et al,
2004). The PH domain immediately follows the C-terminus of
the BAR domain; such a BAR-PH motif is essential for Rab5
binding. The same motif has also been found in a homolog
Rab5 effector APPL2, centaurin-b family members, GRAF2,
and oligophrenin (Habermann, 2004), but the 3D structure
organization of BAR-PH motif and its functional implication
remained elusive until now.
In order to address the functional roles of the BAR-PH
motif in APPL1 and related proteins, we have carried out
structure-function studies on human APPL1 and determined
the crystal structures of the Rab5-binding region of APPL1 as
well as the BAR domain alone. The results show that two
BAR-PH molecules form an integrated, symmetric homodi-
mer, and the PH domain has extensive intermolecular inter-
actions with the BAR domain. The BAR dimer of APPL1 has a
stronger curvature than other reported BAR structures.
Further mutagenesis analyses allowed us to identify the
binding sites on both APPL1 and Rab5. In sharp contrast to
the presumed conﬂict between concurrent membrane asso-
ciation and GTPase binding by the BAR dimer (Habermann,
2004), the novel binding mode of the BAR-PH dimer should
permit simultaneous interactions with both.
Results
Protein expression and crystallography
Recombinant proteins of human APPL1 N-terminal fragments
including the BAR (residues 5 265) and BAR-PH domains
(residues 5 385) were expressed in Escherichia coli, then
puriﬁed using His tag afﬁnity chromatography. The samples
were crystallized after removing the tag with thrombin,
which generated a four-residue (Gly–Ser–His–Met) peptide
N-terminal to the native Asp5 residue.
The BAR domain crystal diffracted up to 1.8-A ˚ resolution
on a beamline at the Argonne Advanced Photon Source
(APS) synchrotron facility. The crystal belongs to P21212
space group. Phases of the structural factors were determined
using the Se-Met-based single-wavelength anomalous
dispersion (SAD) method (Supplementary data). There is
one APPL1 BAR molecule per asymmetric unit, with B41%
solvent content. Regions of the N-terminus (up to Thr12),
Leu75 Asp79, and C-terminus (i.e., Pro260 Asp265) were
missing from the ﬁnal reﬁned model because of lack of
interpretable electron density.
The BAR-PH crystal diffracted to 2.05-A ˚ resolution at the
synchrotron facility. The crystal also belongs to P21212 space
group. There is one APPL1 BAR-PH molecule per asymmetric
unit, with B45% solvent content. Phases of this crystal form
were calculated using a combination of molecular replace-
ment and SAD methods, and further improved with density
modiﬁcation. Regions of N-terminal non-native tripeptide
(i.e., Gly–Ser–His), Gly76 Asp78, Asn288 Ser295, and
C-terminus (i.e., Ser380 Glu385) lacked interpretable electron
density and were omitted from the ﬁnal reﬁned model. Data
collection and reﬁnement statistics are summarized in Table I.
BAR domain structure and dimerization
From the two crystal forms of APPL1 peptides, we obtained
two crystallographically independent BAR domain models. In
both cases, the APPL1 BAR domain has three long helices,
namely a1, a2, and a3. In addition, the APPL1 BAR domain
contains an extra nine-turn a-helix, a4 (Figure 1;
Supplementary Figure 1). The two models could be super-
imposed onto each other with a moderate, 1.3-A ˚,C a-atom
root mean square deviation (r.m.s.d.) if ﬂexible terminal and
loop regions (i.e., residues 5 18, 75 79, 151 153, and
255 265) were omitted. Thus, the overall structure of the
BAR domain remains the same either alone or in the context
of BAR-PH motif.
Table I Crystallography data collection and reﬁnement statistics
(a) Data statistics BAR BAR PH
Wavelength (A ˚) 0.9793 1.0000
Space group P21212P 2 1212
Unit cell
a (A ˚) 53.0 103.7
b 129.2 105.7
c 36.9 36.4
Resolution (A ˚) 50 (1.86)
a 1.80 50 (2.12) 2.05
Rmerge (%) 8.1 (44.0) 6.7 (43.2)
Number of reﬂections 23548 (1897) 23286 (1989)
Completeness (%) 96.1 (78.5) 89.9 (78.0)
Redundancy 3.3 (3.1) 4.5 (3.2)
I/s(I) 10.2 (2.2) 16.4 (2.7)
(b) Reﬁnement statistics
Rworking (%)/# of reﬂections
b 21.2/21703 20.5/20882
Rfree (%)/# of reﬂections
b 25.5/1200 26.8/1200
Number of non-hydrogen
atoms
Protein 1990 2943
Solvent 147 157
R.m.s.d. from ideal values
Bond length (A ˚)/angle (deg) 0.016/1.51 0.013/1.30
Ramachandran plot (%)
c 98.3/1.7/0/0 94.7/5.3/0/0
Average B-factor (A ˚ 2)
Protein 34.1 (25.8)
d 47.9 (38.3)
d
Solvent 41.4 47.7
aNumbers in parentheses are the corresponding numbers for the
highest-resolution shell, unless otherwise mentioned.
bReﬂections of |Fobs|40.0.
cCalculated using PROCHECK. Numbers reﬂect the percentage of
residues in the core, allowed, generously allowed and disallowed
regions, respectively.
dWilson B-factors calculated using a 4A ˚ cutoff.
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tightly packed dimer, which assumes a crescent-like shape, a
hallmark of the BAR dimer structure (Figure 1). In the BAR
dimer, the helix a1 forms an antiparallel helix bundle with its
symmetry counterpart, giving shape to the concave surface of
the crescent-like dimer. Helix a4 packs against a3 of the
symmetry mate on the convex side of the dimer, and its
C-terminus points to the tip of the crescent. Over 4400A ˚ 2
solvent accessible surface (SAS) from each protomer is buried
in the dimer interface. The addition of each a4 helix to the
canonical BAR motif results in approximate 1900A ˚ 2 buried
SAS on the two protomers, corresponding to over 40% of the
total buried SAS.
Although the overall folding of APPL1 BAR domain is
similar to previously reported BAR domain 3D structures
(i.e., arfaptin2, PDB ﬁle 1I4T; amphiphysin, 1URU; and en-
dophilin, 1ZWW), those structures are in general more
similar to each other than to the APPL1 BAR domain. For
instance, using 150 Ca atoms of the common helical regions,
the r.m.s.d. values between the dimer of APPL1 BAR and
1I4T, 1URU, and 1ZWW were 3.7, 3.8, and 4.4A ˚, respectively,
while those among 1I4T, 1URU, and 1ZWW range between
2.4 and 2.6A ˚. In addition, the APPL1 a1 and a2 helices lack
extensive patches of positively charged aa residues on the
concave surface (Figure 2); such patches are thought to be
essential for some BAR containing proteins to induce in vitro
tubule formation (Carlton et al, 2004).
The curvature of the concave face of the BAR dimer is
thought to play an important role in membrane bending and/
or curvature sensing (Habermann, 2004). We implemented a
computing algorithm to calculate the curvature radius (rC)
and found that the APPL1 BAR dimer has an rC about 55A ˚
(Supplementary data; Supplementary Figure 2), signiﬁcantly
smaller than the rC values of other BAR dimers (Peter et al,
2004). Thus, the APPL1 BAR dimer has the strongest curva-
ture among known BAR dimer structures.
Structure of the APPL1 PH domain
The APPL1 PH domain encompasses residues
Asn276 Leu379 and has a typical PH folding
(Supplementary Figure 3). The core structure of PH domain
consists of a pair of nearly orthogonal b-sheets of four and
three antiparallel b-strands (b1–b2–b3–b4 and b5–b6–b7;
Supplementary Figure 1). The C-terminal a-helix, aC, packs
against both b-sheets and contributes to the core of the
domain. In the PH domain, connecting loops are named
after the preceding b-strands (e.g., the loop between b1 and
b2 is called L1, etc). The canonical ligand-binding site is
composed of b1, L1, b2, L3, and L6 (exempliﬁed in the crystal
structure of PLC-d1, PDB ﬁle 1MAI) and, roughly speaking, is
conﬁned to a triangular area with L1, L3, and L6 as the three
vertices. Some positively charged or polar residues that have
been previously identiﬁed as critical for lipid binding in this
ligand-binding triangle are not conserved in APPL1
(Supplementary Figures 1 and 3), consistent with the fact
that APPL1 alone lacks membrane binding ability.
Packing of the BAR and PH domains
In our crystal structure of the APPL1 BAR-PH dimer, the two
PH domains are located at the opposite ends of the crescent-
shaped dimer, and each has fairly extensive contact with the
BAR domain of its symmetry mate (Figure 1). The addition of
the PH domain expands the BAR dimer in the longest
dimension from 140 to 170A ˚, but hardly changes the height
of the dimer (i.e., the dimension along the two-fold axis
direction) and its curvature. Using its b1, b2, L3, and L7
regions, the PH domain contacts the BAR domain of its
symmetry mate in two places (Figures 1B, C and 3;
Supplementary Figure 3). First, the motif of D
15SPxxR
20
(where x stands for any aa residue) at the N-terminal of
BAR domain contacts b1, b2, and L3 regions of PH domain.
For instance, the hydroxyl group of Tyr283 in b1f o r m sa2 . 6 - A ˚
hydrogen bond with the backbone carbonyl oxygen of
Asp15 (Figure 3A). Second, the conserved D
334xxDRRYCF
342
motif in the loop L7 of the PH domain is directly in contact
with the loop connecting a2 and a3 in the BAR domain
(Figure 3B). The buried SAS from each BAR-PH molecule in
Figure 2 Electrostatic potential distribution of APPL1. Electrostatic
potentials of APPL1 BAR-PH protomer (left) and dimer (middle and
right) are mapped on their molecular surfaces. Negatively charged
regions (p 0.5V) are colored red, positively charged regions
(Xþ0.5V) blue, and neutral regions gray. The right view is looking
down along the dyad axis of the dimer at the concave surface, and
the side view differs by 901. Clusters of acidic residues which are
potentially important in Rab5 binding are circled. This ﬁgure was
generated with the program CCP4mg.
Figure 1 Crystal structure of the APPL1 BAR-PH dimer. (A) The
overall structure of the dimer. The left view is along the direction of
the dyad symmetry and on the concave surface, and the right view
differs by 901. One protomer is shown in ribbon diagram, and the
other is shown in molecular surface model. Helix a1 is colored
yellow, a2 magenta, a3 green, a4 blue, and PH domain red. (B, C)A
close view of the BAR–PH interface. These images were generated
using the program PyMol.
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domain, the buried SAS is 50% larger than that of the dimer
formed by BAR domain alone (4400A ˚ 2). The canonical
‘ligand’-binding triangle of the PH domain is oriented about
601 from the concave side of the BAR dimmer, so that both
the PH triangle and BAR concave surface could be brought
within the vicinity of a curved membrane simultaneously.
Nevertheless, as discussed earlier, key residues for lipid
interaction are not conserved in APPL1. The C-terminus of
PH is exposed to solvent in the dimer, consistent with the fact
that it connects to the C-terminal region including the PTB
domain.
Because of the interaction between D
15SPxxR
20 motif and
PH domain, the rest N-terminus peptide (residues 5 12)
clearly became ordered in the BAR-PH crystal structure, in
comparison to the BAR domain-alone crystal structure, where
residues N-terminal to Leu13 were invisible in the electron
density map. The ﬁxed N-terminal peptide in the BAR-PH
structure has an extended backbone conformation between
Met4 (remnant from the His-tag cleavage) and Pro8, followed
by a one-turn 310 helix (Figure 3C). This region has several
important intramolecular contacts mainly with helices a1 and
a3. For instance, the Leu7 side chain inserts between the
aromatic rings of Phe26 in a1 and Phe182 in a3. Meanwhile,
the side chain of Asn186 forms two hydrogen bonds with the
backbone amide and carbonyl groups of Leu7, respectively.
All these hydrophobic and hydrogen bond interactions
appear conserved among BAR-PH containing proteins
(Supplementary Figure 1). Furthermore, the N-terminus is
surrounded by a number of regions from the dimer partner,
including the helix a4 and ﬂexible loop connecting a1 and a2
(where residues 76 78 were mobile in the crystal structure).
For instance, Lys6’ (where the prime stands for the dimer
partner) forms a salt bridge with Asp243 in a4 between the
protomers. In addition, Ile9’ forms hydrophobic interactions
with Met247, Ile251, and Leu254 in a4 (Figure 3C).
To investigate roles of the BAR PH interaction in solution,
a double point mutation, S16E/P17E, at the BAR PH inter-
face was made. These residues are located in the region
N-terminal to the BAR domain and form close contacts with
b2 and L3 of the PH domain (Figure 3A). The recombinant
protein of S16E/P17E double mutant in the context of BAR-
PH was expressed predominantly in the insoluble fraction of
cell lysate; however, the same mutations behaved normal in
the BAR-only construct (data not shown). Moreover, expres-
sion of the APPL1 PH domain alone in E. coli did not produce
soluble recombinant protein. The data suggest that the dimer
interaction between PH and BAR domains is critical for the
solubility and stability of the APPL1 PH domain. Consistent
with this, our analytical ultracentrifugation (AUC) data
showed that BAR-PH protein has a higher dimerization
afﬁnity in solution (kd¼0.34nM) than BAR domain alone
(kd¼0.13mM; Supplementary data).
APPL1 Rab5 interaction in solution
To study APPL1 Rab5 interaction in solution, we performed
glutathione S-transferase (GST)-mediated pull-down assays.
The APPL1 BAR-PH domain (residues 5 385) and a longer
fragment with a 40-residue extension downstream of the PH
domain, APPL1 (5 419), were each effectively pulled down
by GTP-bound GST Rab5 fusion protein (Figure 4). The
APPL1 protein was pulled down by either WT Rab5 pre-
loaded with non-hydrolysable GTP analog (GppNHp) or
Rab5-Q79L defective in GTP hydrolysis (with or without
preloaded GTP analog), but could not be effectively pulled
down by either the WT Rab5 preloaded with GDP or Rab5-
S34N defective in GTP binding (Figure 4 and data not
shown). In contrast to the BAR-PH domain, we conﬁrmed
Figure 3 APPL1 domain packing. (A, B), Stereoviews of two major
interacting regions between the PH and BAR domains. The PH
domain from one APPL1 protomer is colored gray, and the BAR
domain from the dimer-mate is colored yellow. Helix backbones are
shown in ribbon representation, otherwise in ropes. Side-chain
and/or main-chain atoms of selected residues are shown in stick
models. Nitrogen atoms are colored blue, oxygen red, and sulfur
green. Hydrogen bonds (o3.0A ˚) are shown as dash-lines. Note that
most residues displayed are highly conserved among the known
BAR-PH containing proteins (Supplementary Figure 1). (C) Stereo-
view of interactions of the APPL1 N-terminal region. The two
protomers are colored gray and yellow, respectively. This ﬁgure was
generated with the programs Molscript and Raster3D.
Figure 4 Pull-down analysis of APPL1-Rab interaction. GST fusion
proteins of Rab5, Rab21, and Rab22 were used to pull down His-
tagged APPL1 (5 385) and (5 419) fragments in the presence of
GDP or GTP analog (GppNHp). The results were analyzed with
SDS–PAGE and anti-His Western blot.
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directly interact with Rab5 (data not shown) (Miaczynska
et al, 2004). Furthermore, using different Rab5 truncation
variants, we demonstrated that the N-terminus (residues
1 15) and C-terminus (residues 185 215) of Rab5 are dis-
pensable for interaction with APPL1 (Figure 4).
Binding afﬁnity between full-length Rab5-Q79L and APPL1
(5 419) was quantitatively determined in a surface plasmon
resonance (SPR) experiment. Rab5 was coupled to the SPR
biosensor chip in random orientations, and APPL1 (5 419)
was applied as the analyte at concentrations of 0.15 12mM
(Supplementary Figure 4). The dissociation constant, kd, for
the Rab5 APPL1 interaction measured from this experi-
ment was 0.9 (70.7)mM, with kon and koff of 1.3
(70.6) 10
3M
 1s
 1, and 1.2 (70.4) 10
 3s
 1, respec-
tively. This kd value is typical for an interaction between a
Rab and its effectors (Eathiraj et al, 2005).
A major Rab5-binding site in the PH domain
To identify Rab5-binding site(s) in APPL1, GST Rab5-Q79L
(full length) was used to pull down APPL1 variants having
surface point mutations. The WT APPL1 (5 419) fragment
was used as the parental construct for the mutagenesis,
because this fragment is easily distinguishable from
GST Rab5 by size on SDS–PAGE gels without the need for
Western blot analysis. A total of 31 point mutations were
made at 27 distinct, solvent-exposed positions (Figure 5;
Supplementary Figures 1 and 3), based on the structural
information of BAR-PH motif. Most of these point mutations
were located in the PH domain or near the BAR PH interface,
which are the surface regions most conserved between
APPL1 and APPL2 (Supplementary Figure 5). Substitution
mutants were designed to maximize potential mutational
effects on Rab5 binding (e.g., by ﬂipping charges or switching
between hydrophobic and hydrophilic residues) without dis-
rupting the overall structure. In addition, the ﬂexible L1 loop
(residues 289 294) was truncated and replaced with one Gly
residue. All of these APPL1 variants, as well as the WT
construct, were expressed in E. coli, with comparable yields
from the soluble fractions (data not shown), in contrast to the
mutations at BAR PH interface mentioned earlier. This sug-
gested that the thirty or so surface mutations had little effect
on the stability of BAR-PH dimer. Among them, seven mu-
tants, including V25D, N308D, M310K, A318D, G319R, L321D,
and D324A, either abolished or signiﬁcantly reduced (i.e.,
retaining o30%) Rab5 binding compared with the WT
APPL1 (Figure 5A). In the 3D structure, most of these
residues cluster in an elongated surface area formed by b3,
L3, and b4 of the PH domain, deﬁning a major Rab5-binding
site (Figure 5B; Supplementary Figure 3). In addition, the
effect of the V25D mutant suggests that the BAR domain also
contributes to Rab binding either directly or indirectly. On the
other hand, L1 loop seems not to be required for Rab5
binding; signiﬁcance of the apparent, positive effect of the
truncation mutant (Figure 5A) remains to be studied.
We further extended these binding studies and conﬁrmed
the above Rab5-binding site in vivo in the cell, by monitoring
Rab5-mediated APPL1 recruitment to early endosomes in the
cell via confocal microscopy. In this case, the RFP (DsRed-
monomer) Rab5-Q79L fusion protein was expressed in
PC12 cells, targeted to the early endosomes, and recruited
effectively the coexpressed GFP (green ﬂuorescence
protein) APPL1 to these early endosomes (Figure 5C).
Importantly, APPL1 (5 385), that is, the BAR-PH domain,
was sufﬁcient to target to Rab5-Q79L containing early endo-
somes (Figure 5C). In contrast, one of the Rab5-binding
defective mutants (A318D) failed to target the early endo-
somes and exhibited a diffused pattern throughout the cyto-
plasm in the cell (Figure 5C).
Interaction between small GTPase and BAR domain has
been exempliﬁed in a complex crystal structure of Rac and
arfaptin2 before (Tarricone et al, 2001). Based on the follow-
ing observations, however, we excluded the possibility of a
Rac arfaptin2-like binding mode for the Rab5 APPL1 inter-
action. First, the linear dimension of Rab5 is less than 50A ˚,
which is signiﬁcantly smaller than the distance (B60A ˚)
between the putative Rab5-binding site in the PH domain
and the central region of the BAR dimmer, where Rac binds
with arfaptin2. Second, the isolated APPL1 BAR domain did
not bind to Rab5 in our pull-down assay. Third, we mutated
APPL1 Asn52, which is at the position equivalent to Rac-
binding site in arfaptin2, to either a smaller (Ala) or larger
(Arg) side-chain residue, and the mutations showed no effect
on the binding to Rab5.
APPL1 as a Rab21 effector
Rab5 subfamily contains several members, including Rab5,
Rab21, and Rab22. Among them, Rab5 and Rab22 share a
higher overall sequence identity with each other than with
Rab21 (Pereira-Leal and Seabra, 2000). This difference was
used to explain the ability of Rab5 and Rab22, but not Rab21,
to share some common effectors such as EEA1 and rabeno-
syn5 (Kauppi et al, 2002; Eathiraj et al, 2005). Therefore, we
tested APPL1 binding speciﬁcity towards other members in
the Rab5 subfamily, using GST Rab21 (full length) and
GST Rab22 (2 192) to pull down APPL1 (5 419).
Interestingly, APPL1 would bind to Rab21 in a GTP-depen-
dent manner (Figure 4), indicating that APPL1 is an effector
for both Rab5 and Rab21. On the other hand, we were unable
to detect any binding between APPL1 and Rab22 in the pull-
down assay (Figure 4). We could not rule out possible in vivo
interaction between them because our recombinant Rab22
might not have folded correctly in E. coli based on the
following observations: (1) the expression level of Rab22
was 10- to 20-fold lower than Rab5 and Rab21, and (2) the
GTP loading rate of Rab22 was lower too (data not shown).
Therefore, we focused our study on Rab5 and Rab21 for their
interactions with APPL1. We demonstrated that Rab21 and
Rab5 have similar but not identical binding proﬁles towards
APPL1 variants (Figure 5), which may be explained by their
sequence divergence. This differential binding to Rab5 and
Rab21 by APPL1 may allow in vivo analysis of the functional
roles of each Rab APPL1 interaction, for example, by speci-
ﬁcally abolishing one interaction while retaining others.
A novel Rab effector binding mode between
Rab5 and APPL1
Next we investigated the APPL1-binding regions in Rab5.
Since residues responsible for APPL1 binding are likely to be
located in the switch I, switch II, and interswitch regions,
whose conformations change between different nucleotide
binding states, these regions became the main objects of our
investigation. In addition to relevant Rab5 mutations that we
made in previous studies, several point mutations in the Rab5
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binding. We found that point mutations in the 42 48 region
signiﬁcantly reduced APPL1 binding, while L38R, Q49A,
E50A, and I53N showed little or no detectable effect
(Figure 6A). Consistent with our previous structural studies
on Rab5–rabaptin5 interaction (Zhu et al, 2004), all muta-
Figure 5 Mutational analyses of APPL1. (A) Quantifying the Rab binding ability of APPL1 variants. The Rab5- and Rab21 binding abilities of
APPL1 variants relative to that of WTAPPL1 (5 419) were estimated based on chemiluminescence-labeled Western blot (see the Materials and
methods) and shown as the white and gray bars, respectively. Standard deviations calculated from multiple experiments were represented by
the thin lines. (B) Mutational effects on binding to Rab5 and Rab21. Distribution of point mutations is shown on the molecular surface of the
BAR-PH dimer where the two protomers are colored gray and light green, respectively. APPL1 mutations that affect binding strongly
(i.e., o30% binding comparing to WT) are colored red; otherwise, the mutants are colored blue. The position showing reversed binding property is
colored yellow. Mutation positions are selectively labeled; note that the PH domain contains residues 276 379. (C) Mutational effects on
APPL1 targeting to Rab5-positive early endosomes in the cell. RFP Rab5-Q79L was coexpressed with GFP APPL1 (full length, FL; BAR-PH
domain; or BAR-PH mutant) in PC12 cells as indicated, followed by confocal ﬂuorescence microscopy. Shown are typical confocal microscopic
images indicating the RFP Rab5-Q79L labeled early endosomes (red) and the colocalization of GFP APPL1 or mutants (green) in the same
cells. Scale bar, 16mm.
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Rab5 rabaptin5 binding (Figure 6A). Furthermore, with the
knowledge of crystal structures of Rab5–rabaptin5 and
Rab22–rabenosyn5 complexes, it is clear that both Rab5
effectors rabaptin5 and rabenosyn5 bind to the so called
invariant hydrophobic triad of Rab5 (i.e., Phe57, Trp74, and
Tyr89) (Merithew et al, 2001). Mutation of any of these
residues usually strongly inhibits the Rab-effector binding
(Zhu et al, 2004; Eathiraj et al, 2005). Interestingly, in our
mutagenesis analysis, the APPL1-binding was affected by
W74R and Y89R, but not by F57R point mutation in Rab5
(Figure 6). Taken together, our results indicate that APPL1
binds to Rab5 regions including the 40 48 loop and switch II,
B30A ˚ across. In addition, we showed that the two effectors,
APPL1 and rapaptin5, could compete for Rab5-binding (data
not shown), conﬁrming that the binding sites of APPL1 and
rabaptin5 on the Rab5 surface overlap with each other.
To further deﬁne the Rab5 APPL1 binding mode, we
performed extensive pull-down analyses between variants
of Rab5 and APPL1, looking for reversal mutants that could
rescue the lost binding ability of others. We identiﬁed one
such pair; APPL1-N308D abolished the binding to Rab5,
while Rab5-L38R had no effect on APPL1 binding.
However, Rab5-L38R was found to bind with APPL1-
N308D, but not with the other tested APPL1 variants of
similar hydrophobic-to-charged mutations, including V25D,
A318D, and L321D (Supplementary Figure 6). This result
suggests that Rab5-L38R restores binding for APPL1-N308D
through complementary, electrostatic, yet speciﬁc interac-
tions. It further implies that the position 308 in the b3 strand
of APPL1 PH domain is in the vicinity of position 38 in the a1
helix of Rab5 in their complex.
Discussion
BAR-stabilized PH domain is essential for Rab5 binding
Since both APPL1 and APPL2 bind to Rab5, their Rab-binding
sites are likely located in a surface region that is conserved
between the two APPL proteins. There are no deletion/
insertion differences in the BAR-PH region between them
(Supplementary Figure 1), and an inspection of the APPL1
BAR-PH dimer surface indicates that the most conserved
surface region is located on the PH domain surface and the
BAR-PH junction (Supplementary Figure 5). Furthermore,
neither PH domain (Miaczynska et al, 2004) nor BAR domain
alone (data not shown) can directly bind Rab5, suggesting
that the dimer interface between PH and BAR domains plays
a critical role in Rab5 binding directly or indirectly. This
binding mode between Rab5 and APPL1 is apparently distinct
from that between Rac and arfaptin, which only requires BAR
dimerization (Tarricone et al, 2001).
To investigate further the structural basis of APPL1 and
Rab5 interaction, we have performed extensive mutagenesis
analyses. A BAR dimer breaking mutant (F210D/F211D) and
the BAR PH interface mutant (S16E/P17E) are both insolu-
ble when expressed in E. coli (data not shown), supporting
the notion that the functional form of APPL1 BAR-PH domain
is a dimer. Importantly a series of surface point mutants are
soluble, allowing us to analyze the in vitro binding properties
between these APPL1 mutants and Rab5 (Figure 5). The
results indicate that Rab5 speciﬁcally binds to the PH domain
of APPL1 in the context of BAR-PH dimer, and this binding
may marginally extend to the neighboring BAR domain. Our
structure-functional analyses are consistent with existing
biochemical data. For example, a previously reported triple
mutation of APPL1 within the PH domain, K280E/Y283C/
G319R, disrupts Rab5 binding (Miaczynska et al, 2004). This
effect can be fully explained based on the importance of the
BAR PH and PH Rab5 interfaces.
Combined results from our mutagenesis pull-down experi-
ments (Figures 4–6), crystal structures of the BAR-PH domain
of APPL1 (Figure 1), and structures of GTPase domain of
human Rab5 in different nucleotide binding modes (Zhu et al,
2003, 2004) clearly explain the requirement of GTP-bound
Rab5 for APPL1 binding. Based on available information, we
have modeled the interaction between the two proteins. With
the assumption that both proteins remain rigid bodies, our
complex model satisﬁes constraints imposed by the mutagen-
esis pull-down results (Figure 7). Over 1200A ˚ 2 SAS area
combined from both the APPL1 dimer and Rab5 would be
buried in their interface. In this putative Rab5 APPL1 bind-
ing mode, APPL1 interface includes L2, b3, L3, and b4
regions. Note that the L3-b4 region showed weak electron
density in the crystal structure, indicating its higher mobility
and possible adaptability in forming a complex with Rab5. On
the Rab5 side, two regions that harbor binding-defective
mutations are involved in the complex formation: the loop
42 48 and switch II (Figure 6). Furthermore, the reversal
mutation pair, Rab5-L38R and APPL1-N308D (Supplementary
Figure 6) would directly interact with each other inside the
interface of our complex model. The bound Rab5 molecules
would extend the concave surface of the APPL1 dimer, with
both the N- and C-termini of Rab5 exposed to solvent.
Considering that there are about 30 residues C-terminal to
our Rab5 model, which are necessary for membrane associa-
Figure 6 Mutational analyses of Rab5. (A) Pull-down assay on
Rab5 variants. Point mutations in switch regions were introduced
in the full-length Rab5-Q79L background of the GST fusion con-
struct. Each mutant was expressed in E. coli, puriﬁed, and equal
amounts of each Rab5 sample was used to pull down recombinant
proteins of His-tagged WT APPL1 (5 419) (top panel) and His-
tagged rabaptin5 (551 862) (bottom panel). The results were
visualized by Coomassie blue stain. (B) Molecular surface model
of Rab5 GTPase domain. Its N-terminus, switch I (SW1) and switch II
(SW2) regions are labeled. Rab5 mutations that have effects and
have no effect on binding are labeled red and blue, respectively. The
position showing reversed binding property with the APPL1 N308D
mutant is colored yellow.
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would allow Rab5 molecules to anchor to the membrane
through the added C-terminal tails and to interact with APPL1
at both ends of the BAR-PH dimer (Figure 7). The Rab5
C-terminal tail is likely ﬂexible, supporting that recruitment
of APPL1 to the endocytic vesicle may not require its direct
contact with the membrane. In the complex, the Rab5 mole-
cule does not block the C-terminus of the PH domain,
allowing peptide extension of the APPL1 molecule from the
BAR-PH domain.
Rab5–APPL1 interaction represents a novel Rab effector
binding mode
In contrast to the a-helix dominant Rab-binding motifs of all
other effectors of known 3D structures (Ostermeier and
Brunger, 1999; Zhu et al, 2004; Eathiraj et al, 2005; Wu
et al, 2005; Wei et al, 2006), the Rab5-binding motif of
APPL1 is mainly composed of two b-strands, b3 and b4,
and their connecting loop L3. Although the exact binding
position on the Rab protein and orientation of the effector
helices may differ among available complex structures, all
these Rab-binding domains interact with the invariant hydro-
phobic triad. However, we have identiﬁed a Rab5 mutation in
the hydrophobic triad, F57R, that does not interfere with
APPL1 binding, but abolishes the binding to another Rab5
effector, rabaptin5 (Figure 6A; Zhu et al, 2004). In contrast,
several point mutations in the switch I region of Rab5 affect
the binding of APPL1 but not rabaptin5. The 42 48 region in
Rab5 has not been previously reported to be involved in
effector binding.
GTPase binding has emerged as a major function of PH
domains in addition to lipid binding (Lemmon, 2004). For
example, PH domains in some guanine nucleotide-exchange
factors (GEF) have been shown to bind directly to their
cognate small GTPases (Rossman et al, 2002, 2003; Lu et al,
2004), and our data now show direct interaction between the
APPL1 PH domain and Rab5. So far, only two crystal struc-
tures of small GTPase PH domain complexes are available.
One is Ran RanBD1 (PDB ﬁle 1RRP). The interactions
between the Ran GTPase domain and RanBD1 PH core
domain is fairly minor, occurring between the switch I region
of the GTPase (equivalent to the 40’s in Rab5) and strand b2
of the PH domain. This interaction alone is unlikely to be
sufﬁcient to form a stable complex. Indeed, Ran has a long
C-terminal peptide beside the GTPase domain, while the PH
domain of RanBD1 has an extra N-terminal peptide. These
two terminal peptides wrap around the partner proteins
forming the major interaction between Ran and RanBD1.
Such an interaction seems not to be required for Rab5 and
APPL1, because the GTPase domain of Rab5 and BAR-PH
domain of APPL1 are sufﬁcient to mediate their interaction.
The second published small GTPase PH complex is that of
Ral Exo84 (PDB ﬁle 1ZC3). In this complex, the PH domain
of Exo84 uses L1, b5, and L6 to interact with the interswitch
and switch II regions of Ral forming an intermolecular
b-sheet extension mediated by the PH b5 strand and
GTPase b2 strand (Jin et al, 2005). Our mutagenesis analysis
points to a different surface region (b3, L3, and b4) of the PH
domain for Rab5 binding. Therefore, the Rab5 APPL1 inter-
action represents a new GTPase PH binding mode.
APPL1 is a representative of BAR-PH containing proteins
Both APPL1 and APPL2 are identiﬁed as Rab5 effectors, and
their overall aa sequences are highly homologous. In parti-
cular, residues on the APPL1 BAR dimer interface, BAR PH
interface, and the presence of the a4 helix seem well con-
served in APPL2 (Supplementary Figure 5). Therefore, APPL2
BAR-PH domain most likely forms a homodimer very similar
to that of APPL1. Furthermore, these conserved structural
features may also extend to other BAR-PH containing proteins
(Supplementary Figure 1; Habermann, 2004). For instance,
no helix breaking aa sequence appears in the middle of their
predicted a4 regions. Based on the APPL1 BAR-PH crystal
structure, we ﬁnd that, in general, the PH domain is more
conserved than the BAR domain, and most of the highly
conserved positions are located closer to the BAR PH inter-
face rather than the central region of the symmetric dimer.
For example, the two major contact regions between PH and
BAR domains (i.e., D
15SPxxR
20 and D
334xxDRRYCF
342) are
conserved at the aa sequence level among BAR-PH containing
proteins. In addition, correlated mutations are present bet-
ween these proteins at the BAR PH interface. Thus, we
propose that all BAR-PH containing proteins share similar
3D structures in the corresponding regions and that the
BAR-PH motif may function as a general structural unit to
interact with membrane-bound proteins and other molecular
moieties.
In some BAR containing proteins, it is proposed that there
exists an amphipathic helix N-terminal to the a1 helix of BAR
domain, and they are called an N-BAR motif (Peter et al,
2004; Gallop et al, 2006). It is suggested that this extra
N-terminal region facilitates membrane binding (or bending).
A similar N-BAR structure was predicted for APPL1 and
APPL2 (Habermann, 2004), but our current APPL1 crystal
structure does not show such a structural motif. Instead, the
N-terminal region assumes an extended conformation and
packs in the groove formed between helices a1 and a3 on the
convex side of the crescent-shaped dimer (Figure 3C). Since
the N-terminal regions of the other BAR-PH containing pro-
teins (Supplementary Figure 1) share similar sequences, we
suggest that none of these proteins contains an N-BAR motif
in their 3D structure.
Figure 7 Putative complex model of the APPL1 BAR-PH dimer and
Rab5. (A) APPL1–Rab5 interaction. The two BAR-PH protomers are
shown in molecular surface models and colored gray and cyan,
respectively. Positions of APPL1 mutations are colored similarly to
Figure 5B. Overlaying APPL1, Rab5 is shown in a green backbone
trace and positioned according to the mutagenesis data; the N-and
C-termini of its GTPase domain are labeled. Rab5 mutants that
affect binding are marked with red spheres, and those having no
effect are marked with blue spheres. Positions of the reversal
mutation pair are labeled. (B) Membrane recruitment of APPL1
mediated by Rab5. The APPL1 BAR-PH protomers are colored gray
and yellow, and APPL1 C-terminal peptides are represented by
ovals. Rab5 molecules are shown in green molecular surface
models, and their membrane anchored C-terminal tails are repre-
sented by red curves.
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domain and the lipid-binding motif in the PH domain
(Supplementary Figure 1) may explain the Rab5-dependent
membrane association of APPL1. In contrast, the PH domains
of centaurin-b1/2 contain the key, basic residues for phos-
phoinositide binding (Dinitto and Lambright, 2006;
Supplementary Figure 1). If their PH domains are oriented
similarly to that in the APPL1 dimer, the canonical (i.e., L1–
L3–L6), ligand-binding triangle in their PH domains likely
contributes to direct membrane association of these proteins.
Functional implications of the BAR-PH structure
While it is suggested that Rab5 APPL1 interaction mediates a
signal transduction pathway between the plasma membrane
and the nucleus, the mechanism by which Rab5 binding
stimulates APPL1 translocation to the nucleus remains elu-
sive. The current BAR-PH structure may help to clarify the
mechanism. Interestingly, the sequence of ‘PKKKENE’ was
identiﬁed in the BAR domain of APPL2 as a potential nuclear
localization signal (Miaczynska et al, 2004). The correspond-
ing region in APPL1 is the solvent exposed loop connecting a2
and a3 at the tip of the dimer (Figure 1B) and has a fairly
conserved sequence (Supplementary Figure 1). In addition,
our preliminary data suggest that there is no detectable
binding between the BAR-PH domain and the C-terminal
region of APPL1 (data not shown), which makes it unlikely
that Rab5 may regulate APPL1 through interference with the
intramolecular interaction of the latter. It seems more prob-
able that the Rab5 APPL1 complex recruits downstream
effectors to propagate the signal transduction process.
Unlike other Rab effectors, APPL1/2 proteins function in
the signaling pathway from the so-called signaling endosome
to nucleus. Our data show that APPL1 interacts with the Rab5
protein using a novel binding mode; it remains to be proven
whether such a binding mode is essential for APPL1 function.
Whereas it has been shown that APPL1 does not bind other
Rab proteins miscellaneously (Miaczynska et al, 2004), we
demonstrate that APPL1 is also an effector of Rab21, indicat-
ing that APPL1 adopts a binding mode shared by both Rab5
and Rab21. It raises the possibility that, besides Rab5, other
members of this Rab subfamily may also be involved in the
APPL1 signaling pathway.
Materials and methods
Protein expression and puriﬁcation
Constructs of human APPL1 (GenBank ID: NP_036228) (5 265) (i.e.,
the BAR domain) and APPL1 (5 385) (i.e., the BAR-PH domain) were
inserted into the vectors pET28a and pET15b (Novagen), respectively,
between NdeIa n dBamHI restriction sites. The N-terminal few
residues in the native sequence are hydrophobic and were deleted in
an attempt to improve the solubility. Point mutations were introduced
into the pET15b-APPL1 (5 419) parental construct using Quick-
Change
TM site-directed mutagenesis kit (Stratagene).
His-tagged proteins of APPL1 (5 265) and APPL1 (5 385) were
expressed as soluble recombinant proteins in BL21 Star
TM (DE3)
strain of E. coli (Invitrogen), and cells were harvested after
induction with 0.1mM isopropyl-b-D-thiogalactopyranoside (IPTG)
for 8h at 251C. The cells were lysed with lysozyme, and the lysate
supernatant was puriﬁed with His-Select
TM afﬁnity beads (Sigma).
In both cases, the His tag was removed with thrombin. After further
puriﬁcation with Resource-Q
TM anion-exchange chromatography
(GE Healthcare), both protein samples were concentrated
to B30mgml
 1 in (20mM Tris–HCl (pH 8.0) and 0.1% (v/v)
b-mercaptoethanol (bM E ) )a n ds t o r e da t 851C until needed. APPL1
(5 419) mutants were expressed similarly. Se-Met-substituted
proteins were expressed in E. coli B834 (DE3) pLysS cells (Novagen)
in minimal media supplemented with 40mgl
 1 Se-Met (Sigma) and
puriﬁed using the same procedure as the native protein.
Recombinant proteins of human Rab5a variants (GenBank ID:
NM_004162), human Rab21 (BC021901), and human Rab22a
(NM_020673) fused with an N-terminal GST were expressed in
BL21 E. coli and puriﬁed with GST-afﬁnity chromatography. The
sample was concentrated to B20mgml
 1 and stored in 1 
phosphate-buffered saline (PBS) with 0.1% (v/v) bME at  801C.
Recombinant protein of human rabaptin5 (551–862) (GenBank ID:
CAA62580) was expressed and puriﬁed as described previously
(Zhai et al, 2003); two additional point mutations, C719S and
C734S, were introduced to reduce aggregation.
Protein crystallization and data collection
Crystals of APPL1 (5–265) were grown at 201C with the hanging
drop vapor diffusion method. The Se-Met incorporated protein
sample diluted to 10–20mgml
 1 was mixed 1:1 (v/v) with the
reservoir solution of 0.1M magnesium formate and 0.1% (v/v)
bME. Crystals were transferred to a cryo-protectant solution
of (88% saturated Li2SO4, 14mM magnesium formate, 20mM
Tris–HCl (pH 8.0), and 0.1% (v/v) bME) by gradually changing the
drop solution in 20min, followed by cooling in liquid nitrogen.
A data set was collected at selenium edge at sector 22 BM of the
Argonne APS facility.
Crystals of APPL1 (5–385) were also grown in hanging drops at
201C. The reservoir contained 6% (w/v) polyethylene glycol 6000
(PEG6K), 0.6M NaCl, and 0.1% (v/v) bME. The crystals were quickly
soaked in a solution of (7.5% (w/v) PEG6K, 0.25M NaCl, and 10%
(v/v) glycerol) and ﬂash-cooled under liquid nitrogen. Both native and
SAD data sets were collected at the APS facility. Analyzing the crystal
content by SDS–PAGE conﬁrmed the integrity of the protein sample.
All data were processed with the program suite HKL2000.
Pull-down assay for analyzing protein–protein interactions
In the Rab5 APPL1 pull-down experiment, 30mg GST Rab fusion
protein (52kDa) was incubated with 60ml of 30% slurry of GSH–
Sepharose 4B (GE Healthcare) at 221C for 30min. Nucleotide
loading reaction was performed on the GSH beads in an exchange
buffer of (1  PBS, 2mM DTT, 1mM MgCl2, 4mM EDTA, and
400mMG p p N H po rG D P )a t2 2 1C for 30min. Increasing the
magnesium ion concentration to 20mM terminated the loading
reaction. Soluble fractions of cell lysate containing all His-tagged
APPL1 (5–419) variants were analyzed by SDS–PAGE to conﬁrm their
comparable expression level and solubility. The GSH resin carrying
nucleotide-loaded GST Rab fusion protein was incubated with B50ml
cell lysate (B200mg APPL1 variant, 50kDa) at 221C for 30min, then
washed three times with 200mlo f( 1   PBS, 2mM DTT, and 4mM
MgCl2)a n dr e s u s p e n d e di n2 0mlo f2  reducing SDS sample buffer.
The sample was subjected to SDS–PAGE analysis, visualized with
C o o m a s s i eb l u es t a i n .T h es a m es a m p l e sw e r ea n a l y z e dw i t h
chemiluminescence Western blot (GE Healthcare) and His-tag anti-
body then detected on ﬁlms which were semi-quantiﬁed using the
computer software ImageJ (http://rsb.info.nih.gov/ij/) including its
default calibration. The relative band intensity of each mutant versus
WT from multiple experiments is shown in Figure 5.
Coordinate deposit
Coordinates and the structural factors of the APPL1 crystal
structures have been deposited to PDB under codes 2Q12 (BAR
domain structure) and 2Q13 (BAR-PH domain structure).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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